As we are still in January, it is a good time to look back at 2006 to identify some of the key events that shaped the biotech industry and its development, particularly in the Midwest.
Here's my list, in order of importance: biofuels, stem cells, BIO 2006 in Chicago, the reshaping and resurgence of Abbott Labs, biogenerics in the U.S., the internationalizati......Full article >>>
announcements by both GE and Siemens were symbolic of this convergence, with the announcement of GE acquiring Abbott's in vitro diagnostics business for over $8 billion, and Siemens' acquisition of Bayer's
diagnostics business and Diagnostics Products Corp. (in July, 2006) for 5.7 billion (about $7.35 billion), which sent shock waves through the industry.
<......Full article >>>
eported throughout the year, the growth of biotech in countries such as Switzerland, China, Israel, Korea, and Japan, is staggering, and I was personally able to witness this through my trips.
I wrote about this earlier, as at least four Midwest nanotech companies raised over $110 million in venture capital financing in 2006, including: Cipla
, Dr. Reddy's
, Sun Pharma
, etc. - took advantage of fire sales by Big Pharma in selling off key assets in Europe (as a result of consolidation). Indian pharma is following the lead of Israeli generic leader Teva Pharmaceutica......
Full article >>>
n equity piece of Boston Scientific
- all in the same deal. Abbott topped off the year with another aggressive acquisition of Kos Pharmaceuticals
, a cardiovascular drug specialty pharma company, and almost in the same breath, disposal of its in vitro diagnostics business.
No, Abbott has not exited the diag......Full article >>>
of many major diseases, many states took legislative initiatives to accelerate the finding and development of new stem cell-based research and therapies. Not bad considering that Wisconsin was the forerunner of much of this research, and holds a number of key patents. The promise of stem cell-based therapy is still early but exciting, and it may change the course of therapy as we know it.
......Full article >>>
llion to net farm income by 2025.
For those of you who scoff at this, when I visited Brazil during 2006, I personally witnessed how this country had harnessed biotechnology with their sugar cane crop to become self sufficient in gas. Even President Bush
jumped on the biofuels bandwagon in his 2007 State of the Union address when he establ......Full article >>>
org">Illinois Biotechnology Industry Organization. He can be reached at email@example.com
The opinions expressed herein or statements made in the above column are solely those of the author, and do not necessarily reflect the views of Wisconsin Technology Network, LLC.
WTN accepts no legal liability or responsibility for any cla......Full article >>>
Source:wistechnology.com By Michael Rosen 01/29/07Related biology technology :1
. Privacy, trust still the biggest barriers to electronic record sharing2
. Just one nanosecond: Clocking events at the nanoscale3
. How to get through tech-sector networking events alive4
. Furious pace of Midwest biotech events marks progress5
. Dispelling the top five myths about attending networking events6
. The state of global biotech: An Ernst & Young perspective7
. Olympics of biotechnology has international flavor8
. Getting noticed in Genetown: Wisconsin biotech on display9
. Madison biotech NimbleGen files for IPO; one of states best-funded firms10
. Wisconsin biotech firm receives $107K NIH grant11
. Manufacturing partnership will move into biotech and biomedical spaces